Vaxcyte (NASDAQ: PCVX) CEO sells 24,461 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vaxcyte, Inc. director and CEO Grant Pickering reported a mix of stock option exercise and share sales in Common Stock on June 18, 2026. He exercised stock options for 225 shares at $1.79 per share and separately reported open-market sales totaling 24,461 shares at prices around $52.50 per share.
Two 1,000-share sales were attributed to children’s trusts that hold shares for his son and daughter, while 22,461 shares were sold from his direct holdings. After these transactions, Pickering holds 496,939 shares directly and 135,215 shares indirectly through trusts. The filing notes the sales were completed under a pre-arranged Rule 10b5-1 trading plan adopted on March 3, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 24,461 shares ($1,284,205)
Net Sell
6 txns
Insider
PICKERING GRANT
Role
CHIEF EXECUTIVE OFFICER
Sold
24,461 shs ($1.28M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 225 | $0.00 | -- |
| Exercise | Common Stock | 225 | $1.79 | $402.75 |
| Sale | Common Stock | 225 | $52.51 | $12K |
| Sale | Common Stock | 22,236 | $52.50 | $1.17M |
| Sale | Common Stock | 1,000 | $52.50 | $53K |
| Sale | Common Stock | 1,000 | $52.50 | $53K |
Holdings After Transaction:
Stock Option (right to buy) — 0 shares (Direct, null);
Common Stock — 497,164 shares (Direct, null);
Common Stock — 135,215 shares (Indirect, By Children's Trust)
Footnotes (1)
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026. Shares are held directly by a trust for the benefit of the Reporting Person's son. Shares are held directly by a trust for the benefit of the Reporting Person's daughter. Option is fully vested and exercisable.
Key Figures
Shares sold: 24,461 shares
Sale price: $52.50/share
Additional sale price: $52.51/share
+4 more
7 metrics
Shares sold
24,461 shares
Total Common Stock sales reported on June 18, 2026
Sale price
$52.50/share
Price for most Common Stock sales on June 18, 2026
Additional sale price
$52.51/share
Price for a 225-share Common Stock sale
Options exercise price
$1.79/share
Exercise price for 225-share stock option
Shares from option exercise
225 shares
Common Stock acquired via option exercise
Direct holdings after transactions
496,939 shares
Common Stock held directly after June 18, 2026
Indirect holdings after transactions
135,215 shares
Common Stock held through children’s trusts after transactions
Key Terms
Rule 10b5-1 trading plan, open-market sale, Stock Option (right to buy), derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action: open-market sale, transaction_code_description: Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy) with underlying security title Common Stock"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
indirect ownership financial
"direct_or_indirect: I, ownership_type: indirect, nature_of_ownership: By Children's Trust"
FAQ
What did Vaxcyte (PCVX) CEO Grant Pickering report in this Form 4?
Grant Pickering reported exercising options and selling Vaxcyte Common Stock. He exercised options for 225 shares at $1.79 and reported open-market sales totaling 24,461 shares at prices around $52.50 per share on June 18, 2026.
Were any of Grant Pickering’s Vaxcyte (PCVX) sales made under a Rule 10b5-1 plan?
Yes. A footnote states that the sale reported in this Form 4 was effected under a Rule 10b5-1 trading plan adopted on March 3, 2026. Such plans pre-schedule trades, indicating the timing was set in advance rather than decided on the transaction date.
How are the children’s trusts involved in Grant Pickering’s Vaxcyte (PCVX) holdings?
Two 1,000-share sales are reported as indirect transactions by children’s trusts. Footnotes explain these trusts hold shares for his son and daughter. After the transactions, 135,215 shares are reported as held indirectly through these trusts, in addition to his direct holdings.
What stock option activity did Grant Pickering report for Vaxcyte (PCVX)?
He reported exercising a stock option for 225 shares of Vaxcyte Common Stock. The option had a conversion or exercise price of $1.79 per share, was fully vested and exercisable, and related derivative holdings for that option are shown as reduced to zero after the exercise.